Vaccines Webinar | The Post-marketing Life of Vaccines
Welcome from the Chair
2nd Vaccines Webinar
The Post-marketing Life of Vaccines
Dear Colleagues,
It is a great pleasure to announce the upcoming webinar “The post-marketing life of vaccines”, to take place virtually on 27 April 2022, at 2pm CEST = 8am (EDT) = 8pm (CST Asia).
The webinar is organized with the support of MDPI’s journal Vaccines, one of the most important international scientific journals in the field of vaccinology.
The recent experience with the SARS-COV-2 pandemic and the universal mass vaccination that was carried out to fight this emergency is an important lesson for vaccinologists.
Vaccines against SARS-COV-2 were prepared in 8 months and much of the information about the safety, long-term immunogenicity and effectiveness of these vaccines came from post-marketing studies.
Therefore, the research into vaccines does not stop after marketing authorization; important evidence can come from post-marketing and phase IV studies.
Three important scientists will discuss these topics for 20 minutes, in a live presentation on Zoom. The webinar will conclude with a Q&A session, where you will be able to share your thoughts with the speakers. The webinar will be recorded and uploaded to Sciforum.
We look forward to meeting you at the webinar.
Prof. Silvio Tafuri
Editorial Board Member of the Vaccines journal
Date: 27 April 2022
Time: 2:00 pm CEST | 8:00 am EDT | 8:00 pm CST Asia
Webinar ID: 846 2567 1710
Webinar Secretariat: vaccines.webinar@mdpi.com
Chair
Department of Biological Sciences and Human Oncology, University of Bari, Bari, Italy
Silvio Tafuri was born in Brindisi (Italy) on 1980, 17 August. He graduated in Medicine and Surgery at Bari School of Medicine in 2005, In 2008, he achieved post-degree in Public Health, and in 2013, he obtained a Ph.D. in Hygiene, Public Health and Food Safety. He is a consultant with the Apulian Observatory for Epidemiology in the field of vaccination strategies, surveillance of infectious diseases and adverse events following immunization. From 2014 to March 2020, he has served as Assistant Professor of Public Health at the Bari School of Medicine, and from March 2020 to April 2021, as Associate Professor of Public Health. Since April 2021, he has served as a Full Professor of Public Health. He works as a consultant in the Public Health Unit of the Policlinico Bari General Hospital, in which he is charged with the management of vaccination activities; since March 2020, he has worked as Chief of the COVID19 Control Room Unit. He is the author of 250 articles, published in international scientific journals (IF >650, h-index 24); the most of his scientific papers focus on the field of vaccinology and the prevention of infectious diseases.
Invited Speakers
Department of Biological Sciences and Human Oncology, University of Bari, Bari, Italy
Pasquale Stefanizzi was born in Poggiardo (Lecce - Italy) on 1987, 25 May. He graduated in Medicine and Surgery at Parma School of Medicine in 2014; in 2019, he achieved a post-degree in Public Health. He is a consultant of the Apulian Observatory for Epidemiology in the field of vaccination strategies, surveillance of infectious diseases and adverse events following immunization. From July 2020, he has been an Assistant Professor of Public Health at the School of Medicine in Bari. He works as a consultant in the Public Health Unit of the Policlinico Bari General Hospital, in which he is charged with the management of vaccination activities; since March 2020, he has been a member of the COVID19 Control Room Unit. He is member of the National Group of monitoring the safety of vaccines. He is author of over 50 articles, published in international scientific journals; most of his scientific papers focus on the field of vaccinology and the prevention and epidemiology of infectious diseases. He is author of over 50 articles published in international scientific journals; the major part of scientific paper is in the field of vaccinology and of the prevention and epidemiology of infectious diseases.
Public Health Agency of Catalonia, Department of Health of Catalonia, Barcelona, Spain,
Ciber of Epidemiology and Public Health (CIBERESP), Madrid, Spain
Pedro Plans-Rubió is Responsible for the Health Registries, Public Health Agency of Catalonia, Health Department of Catalonia, Spain. He received his MD and PhD from the School of Medicine, University of Barcelona, an MSc in Health Economics from the School of Economics, University of Barcelona, and an MSc in Design of clinical and epidemiological studies from the School of Medicine, University of Barcelona. He is a specialist in Preventive Medicine and Public Health, and expert in the European Commission for assessing public health and health economics projects. His research focuses on the evaluation of medicines, vaccines and health programs, epidemiology of risk factors for chronic diseases and infectious diseases, epidemiology of infectious diseases, sero-epidemiological evaluation of vaccination programs, and cost-effectiveness analysis of medicines and health programs. To date, he has published more than 100 articles in scientific journals, and is the author of the book “Application of the cost-effectiveness of medicines and health programs in the health planning”, Elsevier, 2015.
Webinar Content
Program
|
Speaker/Presentation |
Time in CEST |
|
Prof. Dr. Silvio Tafuri Chair Introduction |
2:00 - 2:20 pm |
|
Dr. Pasquale Stefanizzi Adverse Events Following Immunization and Causality Assessment: Data of Apulian Italian Region |
2:20 - 2:40 pm |
|
Dr. Pedro Plans-Rubió Post-marketing Research of Herd Immunity Effects of COVID-19 Vaccines |
2:40 - 3:00 pm |
|
Q&A Session |
3:00 - 3:15 pm |
|
Closing of Webinar |
3:15 pm |
Relevant SI
The Post-marketing Life of Vaccines
Guest Editors: Prof. Dr. Silvio Tafuri & Dr. Pasquale Stefanizzi
Deadline for manuscript submissions: 30 November 2022
Sponsors and Partners
Organizers
